This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics. This report contains market size and forecasts of Cancer Diagnostics in global, including the following market information:
Global Cancer Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Diagnostics market was valued at US$ 164970 million in 2022 and is projected to reach US$ 230000 million by 2029, at a CAGR of 4.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Platform-based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Diagnostics include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare and C.R. Bard, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Platform-based
Instrument-based
Global Cancer Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Lung Cancer
Colorectal Cancer
Others
Global Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Diagnostics, market overview.
Chapter 2: Global Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Diagnostics Overall Market Size
2.1 Global Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Diagnostics Players in Global Market
3.2 Top Global Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Platform-based
4.1.3 Instrument-based
4.2 By Type - Global Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Others
5.2 By Application - Global Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Cancer Diagnostics Market Size, 2018-2029
7 Cancer Diagnostics Companies Profiles
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Company Summary
7.1.2 Becton, Dickinson and Company Business Overview
7.1.3 Becton, Dickinson and Company Cancer Diagnostics Major Product Offerings
7.1.4 Becton, Dickinson and Company Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Becton, Dickinson and Company Key News & Latest Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Company Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Cancer Diagnostics Major Product Offerings
7.2.4 GE Healthcare Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 GE Healthcare Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Cancer Diagnostics Major Product Offerings
7.3.4 Abbott Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Cancer Diagnostics Major Product Offerings
7.4.4 Roche Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Cancer Diagnostics Major Product Offerings
7.5.4 Thermo Fisher Scientific Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Company Summary
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies Cancer Diagnostics Major Product Offerings
7.6.4 Agilent Technologies Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Agilent Technologies Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Cancer Diagnostics Major Product Offerings
7.7.4 Illumina Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Illumina Key News & Latest Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Company Summary
7.8.2 Siemens Healthcare Business Overview
7.8.3 Siemens Healthcare Cancer Diagnostics Major Product Offerings
7.8.4 Siemens Healthcare Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Siemens Healthcare Key News & Latest Developments
7.9 C.R. Bard
7.9.1 C.R. Bard Company Summary
7.9.2 C.R. Bard Business Overview
7.9.3 C.R. Bard Cancer Diagnostics Major Product Offerings
7.9.4 C.R. Bard Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 C.R. Bard Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Cancer Diagnostics Market Drivers in Global Market
Table 3. Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Cancer Diagnostics in Global Market
Table 5. Top Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Becton, Dickinson and Company Company Summary
Table 31. Becton, Dickinson and Company Cancer Diagnostics Product Offerings
Table 32. Becton, Dickinson and Company Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Becton, Dickinson and Company Key News & Latest Developments
Table 34. GE Healthcare Company Summary
Table 35. GE Healthcare Cancer Diagnostics Product Offerings
Table 36. GE Healthcare Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. GE Healthcare Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Cancer Diagnostics Product Offerings
Table 40. Abbott Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Cancer Diagnostics Product Offerings
Table 44. Roche Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Thermo Fisher Scientific Company Summary
Table 47. Thermo Fisher Scientific Cancer Diagnostics Product Offerings
Table 48. Thermo Fisher Scientific Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Thermo Fisher Scientific Key News & Latest Developments
Table 50. Agilent Technologies Company Summary
Table 51. Agilent Technologies Cancer Diagnostics Product Offerings
Table 52. Agilent Technologies Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Agilent Technologies Key News & Latest Developments
Table 54. Illumina Company Summary
Table 55. Illumina Cancer Diagnostics Product Offerings
Table 56. Illumina Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Illumina Key News & Latest Developments
Table 58. Siemens Healthcare Company Summary
Table 59. Siemens Healthcare Cancer Diagnostics Product Offerings
Table 60. Siemens Healthcare Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Siemens Healthcare Key News & Latest Developments
Table 62. C.R. Bard Company Summary
Table 63. C.R. Bard Cancer Diagnostics Product Offerings
Table 64. C.R. Bard Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. C.R. Bard Key News & Latest Developments
List of Figures
Figure 1. Cancer Diagnostics Segment by Type in 2022
Figure 2. Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Becton, Dickinson and Company Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GE Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Thermo Fisher Scientific Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Agilent Technologies Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Illumina Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Siemens Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. C.R. Bard Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
